Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paroxetine CR for Menopausal Symptoms Post-HT
NCT00225914Phase 4Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Sep 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in menopause comparing Paroxetine CR with Placebo (2 arms). Primary endpoint: Mean change in daily hot flash frequency and severity at 6 weeks. Started Sep 2004; status: completed.
02
Drugs
paroxetine
03
Conditions
menopause
Beyond the preview
Go deeper on NCT00225914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00225914.